Psoriatic Arthritis
News
FDA approves Idacio as eighth adalimumab biosimilar in U.S.
Data for Idacio (adalimumab-aacf) showed safety, efficacy, and immunogenicity similar to Humira.
News
Ustekinumab matches TNF inhibitors for psoriatic arthritis in 3-year, real-world study
A real-world study comparing the interleukin-12/23 inhibitor ustekinumab with tumor necrosis factor inhibitors for psoriatic arthritis found...
News
Vaccination cuts long COVID risk for rheumatic disease patients
Although it’s possible the higher proportion of Omicron cases in vaccinated patients accounted for lower rates of long COVID, differences in...
News
Skinny-label biosimilars provide substantial savings to Medicare
The estimated savings to Medicare during 2015-2020 that resulted from competition with five of the first-to-market biosimilars with skinny labels...
News
Wide variance described in lab monitoring of conventional synthetic DMARDs
“The take-home message of this study is that everyone is doing something different, which means that the system likely has a lot of low-value...
News
New ACR vaccination guideline: Take your best shot
Vaccinate patients with rheumatic and musculoskeletal disease against flu and other vaccine-preventable disease whenever possible, experts say.
Article
Right ankle pain and swelling
Conference Coverage
Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritis
Danish investigators studied how a government-mandated switch from one infliximab biosimilar to another affected patients with inflammatory...
News
Practical pearls guide treatment of psoriasis in tricky areas
Start by ensuring the correct diagnosis, then take advantage of the expanding arsenal of therapies, Dr. Jennifer Soung advised.
News
Therapeutic drug monitoring pays off for arthritis patients
Patients who reduced their dosage of TNF-alpha inhibitor had less treatment failure and similar risk of adverse events, compared with standard...